133 related articles for article (PubMed ID: 10878300)
1. Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine.
Newton JR; Lakhani KH; Wood JL; Baker DJ
Prev Vet Med; 2000 Jul; 46(2):129-41. PubMed ID: 10878300
[TBL] [Abstract][Full Text] [Related]
2. The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses.
Ryan M; Gildea S; Walsh C; Cullinane A
Equine Vet J; 2015 Nov; 47(6):662-6. PubMed ID: 25238593
[TBL] [Abstract][Full Text] [Related]
3. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
Newton JR; Townsend HG; Wood JL; Sinclair R; Hannant D; Mumford JA
Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
[TBL] [Abstract][Full Text] [Related]
4. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.
Wilson WD; Mihalyi JE; Hussey S; Lunn DP
Equine Vet J; 2001 Nov; 33(7):644-50. PubMed ID: 11770984
[TBL] [Abstract][Full Text] [Related]
5. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
Gildea S; Arkins S; Walsh C; Cullinane A
Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
[TBL] [Abstract][Full Text] [Related]
6. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.
Gildea S; Arkins S; Walsh C; Cullinane A
Vaccine; 2011 May; 29(22):3917-22. PubMed ID: 21419776
[TBL] [Abstract][Full Text] [Related]
7. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines.
Gildea S; Quinlivan M; Murphy BA; Cullinane A
Vaccine; 2013 Oct; 31(45):5216-22. PubMed ID: 24021309
[TBL] [Abstract][Full Text] [Related]
8. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings.
Cullinane A; Weld J; Osborne M; Nelly M; Mcbride C; Walsh C
Vet J; 2001 Mar; 161(2):174-85. PubMed ID: 11243687
[TBL] [Abstract][Full Text] [Related]
9. Serological investigation of racehorse vaccination against equine influenza in Morocco.
Dilai M; Piro M; Fougerolle S; El Harrak M; Mahir W; El Mourid R; Legrand L; Paillot R; Fassi Fihri O
Vet Microbiol; 2018 Sep; 223():153-159. PubMed ID: 30173741
[TBL] [Abstract][Full Text] [Related]
10. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus.
Gildea S; Arkins S; Cullinane A
Influenza Other Respir Viruses; 2010 Nov; 4(6):363-72. PubMed ID: 20958930
[TBL] [Abstract][Full Text] [Related]
11. Is there a benefit from an early booster vaccination in the control of equine influenza?
Heldens JG; van Loon AA; van de Zande S
Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
[TBL] [Abstract][Full Text] [Related]
12. Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine.
Wood JM; Mumford J; Folkers C; Scott AM; Schild GC
J Hyg (Lond); 1983 Jun; 90(3):371-84. PubMed ID: 6345659
[TBL] [Abstract][Full Text] [Related]
13. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
Mumford J; Wood JM; Scott AM; Folkers C; Schild GC
J Hyg (Lond); 1983 Jun; 90(3):385-95. PubMed ID: 6306098
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine.
Tabynov K; Kydyrbayev Z; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
Aust Vet J; 2014 Nov; 92(11):450-7. PubMed ID: 25348146
[TBL] [Abstract][Full Text] [Related]
15. Primary vaccination in foals: a comparison of the serological response to equine influenza and equine herpesvirus vaccines administered concurrently or 2 weeks apart.
Allkofer A; Garvey M; Ryan E; Lyons R; Ryan M; Lukaseviciute G; Walsh C; Venner M; Cullinane A
Arch Virol; 2021 Feb; 166(2):571-579. PubMed ID: 33410993
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
Heldens JG; Pouwels HG; van Loon AA
Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
[TBL] [Abstract][Full Text] [Related]
17. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant.
Mumford JA; Wilson H; Hannant D; Jessett DM
Epidemiol Infect; 1994 Apr; 112(2):421-37. PubMed ID: 8150017
[TBL] [Abstract][Full Text] [Related]
18. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
[TBL] [Abstract][Full Text] [Related]
19. Accelerated vaccination schedule provides protective levels of antibody and complete herd immunity to equine influenza.
El-Hage CM; Savage CJ; Minke JM; Ficorilli NP; Watson J; Gilkerson JR
Equine Vet J; 2013 Mar; 45(2):235-9. PubMed ID: 22943193
[TBL] [Abstract][Full Text] [Related]
20. Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.
Fougerolle S; Legrand L; Garrett D; Birand I; Foursin M; D'Ablon X; Bayssat P; Newton RJ; Pronost S; Paillot R
Vaccine; 2016 Jul; 34(33):3787-95. PubMed ID: 27269055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
